Children and Adolescents with Irritable Bowel Syndrome: Treatment and Management

Children and Adolescents with Irritable Bowel Syndrome: Treatment and Management Ankita Wal https://orcid.org/0000-0002-5563-1382 Pranay Wal https://orcid.org/0000-0002-6342-6290 Neha Verma https://orcid.org/0000-0001-6671-1284 Shiv Shanker Pandey https://orcid.org/0000-0002-6650-1364 Karthickeyan Krishnan https://orcid.org/0000-0002-1709-730X Mithun Bhowmick Background:

Irritable bowel syndrome (IBS) is a disorder that causes stomach pain in children and adolescents. It may also impact one's quality of life. IBS is linked to gastrointestinal issues such as diarrhoea and constipation. Despite the identification of several potential pathophysi-ological pathways, the aetiology of IBS remained unknown
Objective:

The aim of this paper is to discuss the diagnosis, pathogenesis, case studies and treatment of Irritable bowel syndrome in children and adolescents.
Methods:

This systematic review covered relevant papers from the previous ten years that were accessible in Science Direct, Elsevier, NCBI, and Web of Science related to the pathophysiology and function of pharmacological drugs such as antidepressants, antispasmodics, prokinetics, and antibiotics in children with irritable bowel syndrome.
Results:

those have been demonstrated to be effective. This article presents case studies including 50-59 children, which demonstrate a favourable acceptable impact that is more effective than a pla-cebo in terms of reducing symptoms and improving the overall quality of life in children who have irritable bowel syndrome. Furthermore, the majority of the pathophysiological explanations and treatment options discussed are based on adult studies. These major issues arose when treating paediatric IBS, and they must be addressed in order to properly treat children with IBS. Trials that focus on many combinations of pharmacological and non-pharmacological therapies seem to be more helpful.
Discussion:

In recent years, a number of systematic reviews have been conducted to evaluate the efficacy of medication treatments in children for IBS; however, the dependability of these systemat-ic reviews needs to be further investigated owing to the various experimental designs and levels of evidence used. This article highlights paediatric therapy options, including pharmaceutical medica-tions such as antidepressants, antispasmodics, prokinetics, and antibiotics. The goal is to alleviate IBS symptoms while also enhancing the quality of life for children with this illness.
05 2024 166 177 LiveAll1 1 10.2174/BSP_crossmark_policy eurekaselect.com true Peer Reviewed Single blind Checked with iThenticate 2022-04-23 2022-08-13 2022-09-02 2023-10-05 10.2174/1573396319666221128094843 https://www.eurekaselect.com/211287/article https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/article/download?doi=10.2174/1573396319666221128094843 https://www.eurekaselect.com/211287/article J Clin Med Lacy B. 6 99 2017 10.3390/jcm6110099 Lacy B.; Patel N.; Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med 2017,6(11),99 Front Microbiol Chong P.P. 10 1136 2019 10.3389/fmicb.2019.01136 Chong P.P.; Chin V.K.; Looi C.Y.; Wong W.F.; Madhavan P.; Yong V.C.; The microbiome and irritable bowel syndrome-a review on the pathophysiology, current research and future therapy. Front Microbiol 2019,10,1136 J Pediatr Saps M. 154 322 2009 10.1016/j.jpeds.2008.09.047 Saps M.; Seshadri R.; Sztainberg M.; Schaffer G.; Marshall B.M.; Di Lorenzo C.; A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr 2009,154(3),322-326 Clin Colon Rectal Surg Occhipinti K 25 046 2012 10.1055/s-0032-1301759 Occhipinti K; Smith JW; Irritable bowel syndrome: A review and update. Clin Colon Rectal Surg 2012,25(1),046-52 Lancet Talley N.J. 358 2061 2001 10.1016/S0140-6736(01)07103-3 Talley N.J.; Serotoninergic neuroenteric modulators. Lancet 2001,358(9298),2061-2068 Clin Gastroenterol Hepatol Dunlop S.P. 3 349 2005 10.1016/S1542-3565(04)00726-8 Dunlop S.P.; Coleman N.S.; Blackshaw E.; Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005,3(4),349-357 Gastroenterology Coates M.D. 126 1657 2004 10.1053/j.gastro.2004.03.013 Coates M.D.; Mahoney C.R.; Linden D.R.; Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1. Gastroenterology 2004,126(7),1657-1664 Johns hopskin medicine. Irritable bowel syndrome in chidren. Available from: Pan Afr Med J Adeniyi O.F. 28 93 2017 10.11604/pamj.2017.28.93.11512 Adeniyi O.F.; Lesi O.A.; Olatona F.A.; Esezobor C.I.; Ikobah J.M.; Irritable bowel syndrome in adolescents in Lagos. Pan Afr Med J 2017,28(1),93 J Neurogastroenterol Motil Rajindrajith S. 18 298 2012 10.5056/jnm.2012.18.3.298 Rajindrajith S.; Devanarayana N.M.; Subtypes and symptomatology of irritable bowel syndrome in children and adolescents: A school-based survey using Rome III criteria. J Neurogastroenterol Motil 2012,18(3),298-304 J Pediatr Gastroenterol Nutr Lu P.L. 64 e137 2017 10.1097/MPG.0000000000001391 Lu P.L.; Velasco-Benítez C.A.; Saps M.; Sex, age, and prevalence of pediatric irritable bowel syndrome and constipation in Colombia: A Population-based Study. J Pediatr Gastroenterol Nutr 2017,64(6),e137-e141 Gastroenterol Res Pract Zhu X. 2014 198461 2014 Zhu X.; Chen W.; Zhu X.; Shen Y.; A cross-sectional study of risk factors for irritable bowel syndrome in children 8-13 years of age in Suzhou, China. Gastroenterol Res Pract 2014,2014,198461 Digestion Simrén M. 63 108 2001 10.1159/000051878 Simrén M.; Månsson A.; Langkilde A.M.; Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001,63(2),108-115 J Hum Nutr Diet Hayes P. 27 36 2014 10.1111/jhn.12114 Hayes P.; Corish C.; O’Mahony E.; Quigley E.M.M.; A dietary survey of patients with irritable bowel syndrome. J Hum Nutr Diet 2014,27(Suppl. 2),36-47 Pediatrics Dong L. 116 e393 2005 10.1542/peds.2004-2764 Dong L.; Dingguo L.; Xiaoxing X.; Hanming L.; An epidemiologic study of irritable bowel syndrome in adolescents and children in China: A school-based study. Pediatrics 2005,116(3),e393-e396 J Gastroenterol Hepatol Khayyatzadeh S.S. 33 404 2018 10.1111/jgh.13908 Khayyatzadeh S.S.; Kazemi-Bajestani S.M.R.; Mirmousavi S.J.; Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls. J Gastroenterol Hepatol 2018,33(2),404-410 J Hum Nutr Diet Parker T.J. 8 159 1995 10.1111/j.1365-277X.1995.tb00308.x Parker T.J.; Naylor S.J.; Riordan A.M.; Hunter J.O.; Management of patients with food intolerance in irritable bowel syndrome: The development and use of an exclusion diet. J Hum Nutr Diet 1995,8(3),159-166 Am J Gastroenterol Böhn L. 108 634 2013 10.1038/ajg.2013.105 Böhn L.; Störsrud S.; Törnblom H.; Bengtsson U.; Simrén M.; Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013,108(5),634-641 Eur J Clin Nutr Monsbakken K.W. 60 667 2006 10.1038/sj.ejcn.1602367 Monsbakken K.W.; Vandvik P.O.; Farup P.G.; Perceived food intolerance in subjects with irritable bowel syndrome-etiology, prevalence and consequences. Eur J Clin Nutr 2006,60(5),667-672 Neurogastroenterol Motil Schwille-Kiuntke J. 23 e479 2011 10.1111/j.1365-2982.2011.01779.x Schwille-Kiuntke J.; Enck P.; Zendler C.; Postinfectious irritable bowel syndrome: Follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil 2011,23(11),e479-e488 Am J Gastroenterol Thabane M. 105 933 2010 10.1038/ajg.2010.74 Thabane M.; Simunovic M.; Akhtar-Danesh N.; An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol 2010,105(4),933-939 Neurogastroenterol Motil Mearin F. 24 791 2012 10.1111/j.1365-2982.2012.01992.x Mearin F.; Lacy B.E.; Diagnostic criteria in IBS: Useful or not? Neurogastroenterol Motil 2012,24(9),791-801 J Gastrointestin Liver Dis Drossman D.A. 15 237 2006 Drossman D.A.; Dumitrascu D.L.; Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006,15(3),237-241 Am J Gastroenterol Spiegel B.M.R. 105 848 2010 10.1038/ajg.2010.47 Spiegel B.M.R.; Farid M.; Esrailian E.; Talley J.; Chang L.; Is irritable bowel syndrome a diagnosis of exclusion?: A survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010,105(4),848-858 Gut Camilleri M. 51 i34 2002 10.1136/gut.51.suppl_1.i34 Camilleri M.; Testing the sensitivity hypothesis in practice: Tools and methods, assumptions and pitfalls. Gut 2002,51(Suppl. 1),i34-i40 J Pediatr Halac U. 156 60 2010 10.1016/j.jpeds.2009.06.062 Halac U.; Noble A.; Faure C.; Rectal sensory threshold for pain is a diagnostic marker of irritable bowel syndrome and functional abdominal pain in children. J Pediatr 2010,156(1),60-65.e1 J Pediatr Faure C. 150 66 2007 10.1016/j.jpeds.2006.08.072 Faure C.; Wieckowska A.; Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr 2007,150(1),66-71 J Pediatr Gastroenterol Nutr Miranda A. 47 682 2008 10.1097/01.mpg.0000338958.94313.99 Miranda A.; Early life events and the development of visceral hyperalgesia. J Pediatr Gastroenterol Nutr 2008,47(5),682-684 Gastroenterology Van Ginkel R. 120 31 2001 10.1053/gast.2001.20898 Van Ginkel R.; Voskuijl W.P.; Benninga M.A.; Taminiau J.A.J.M.; Boeckxstaens G.E.; Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome. Gastroenterology 2001,120(1),31-38 J Pediatr Di Lorenzo C. 139 838 2001 10.1067/mpd.2001.118883 Di Lorenzo C.; Youssef N.N.; Sigurdsson L.; Scharff L.; Griffiths J.; Wald A.; Visceral hyperalgesia in children with functional abdominal pain. J Pediatr 2001,139(6),838-843 Gastroenterology Bouin M. 122 1771 2002 10.1053/gast.2002.33601 Bouin M.; Plourde V.; Boivin M.; Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002,122(7),1771-1777 J Neurogastroenterol Motil Lee H. 19 244 2013 10.5056/jnm.2013.19.2.244 Lee H.; Park J.H.; Park D.I.; Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J Neurogastroenterol Motil 2013,19(2),244-250 J Neurogastroenterol Motil Spiller R. 18 258 2012 10.5056/jnm.2012.18.3.258 Spiller R.; Lam C.; An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012,18(3),258-268 Nat Rev Dis Primers Enck P. 2 16014 2016 10.1038/nrdp.2016.14 Enck P.; Aziz Q.; Barbara G.; Irritable bowel syndrome. Nat Rev Dis Primers 2016,2(1),16014 Psychosom Med Sundin J. 79 857 2017 10.1097/PSY.0000000000000470 Sundin J.; Öhman L.; Simrén M.; Understanding the gut microbiota in inflammatory and functional gastrointestinal diseases. Psychosom Med 2017,79(8),857-867 Gastroenterology Saulnier D.M. 141 1782 2011 10.1053/j.gastro.2011.06.072 Saulnier D.M.; Riehle K.; Mistretta T.A.; Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011,141(5),1782-1791 Gut Microbes Shankar V. 4 347 2013 10.4161/gmic.24827 Shankar V.; Agans R.; Holmes B.; Raymer M.; Paliy O.; Do gut microbial communities differ in pediatric IBS and health? Gut Microbes 2013,4(4),347-352 Am J Gastroenterol Rigsbee L. 107 1740 2012 10.1038/ajg.2012.287 Rigsbee L.; Agans R.; Shankar V.; Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2012,107(11),1740-1751 Neurogastroenterol Motil Crouzet L. 25 e272 2013 10.1111/nmo.12103 Crouzet L.; Gaultier E.; Del’Homme C.; The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 2013,25(4),e272-e282 J Pediatr Gastroenterol Nutr Treem W.R. 23 280 1996 10.1097/00005176-199610000-00013 Treem W.R.; Ahsan N.; Kastoff G.; Hyams J.S.; Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: In vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996,23(3),280-286 Gastroenterology Gershon M.D. 132 397 2007 10.1053/j.gastro.2006.11.002 Gershon M.D.; Tack J.; The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology 2007,132(1),397-414 Hosp Pract Gershon MD 34 31-52, 35-38 1999 10.3810/hp.1999.07.153 Gershon MD; The enteric nervous system: A second brain. Hosp Pract 1999,34(7),31-52, 35-38 J Neurogastroenterol Motil Farzaei M.H. 22 558 2016 10.5056/jnm16001 Farzaei M.H.; Bahramsoltani R.; Abdollahi M.; Rahimi R.; The role of visceral hypersensitivity in irritable bowel syndrome: Pharmacological targets and novel treatments. J Neurogastroenterol Motil 2016,22(4),558-574 Tech Coloproctol Stasi C. 18 613 2014 10.1007/s10151-013-1106-8 Stasi C.; Bellini M.; Bassotti G.; Blandizzi C.; Milani S.; Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol 2014,18(7),613-621 Curr Opin Pharmacol Gershon M. 3 600 2003 10.1016/j.coph.2003.07.005 Gershon M.; Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol 2003,3(6),600-607 Am J Manag Care Crowell M.D. 7 S252 2001 Crowell M.D.; The role of serotonin in the pathophysiology of irritable bowel syndrome. Am J Manag Care 2001,7(8)(Suppl.),S252-S260 Trends Mol Med Colucci R. 14 295 2008 10.1016/j.molmed.2008.05.001 Colucci R.; Blandizzi C.; Bellini M.; Ghisu N.; Tonini M.; Del Tacca M.; The genetics of the serotonin transporter and irritable bowel syndrome. Trends Mol Med 2008,14(7),295-304 Biol Res Nurs Jarrett M.E. 9 161 2007 10.1177/1099800407307822 Jarrett M.E.; Kohen R.; Cain K.C.; Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs 2007,9(2),161-169 Neurogastroenterol Motil 18 957 2006 10.1111/j.1365-2982.2006.00854.x geeraerts, van oudenhove, tack. Serotonin transporter gene polymorphisms in irritable bowel syndrome. Neurogastroenterol Motil 2006,18(11),957-959 J Clin Gastroenterol Sha W. 43 123 2009 10.1097/MCG.0b013e318157187a Sha W.; Pasricha P.J.; Chen J.D.Z.; Rhythmic and spatial abnormalities of gastric slow waves in patients with functional dyspepsia. J Clin Gastroenterol 2009,43(2),123-129 Arch Dis Child Cucchiara S. 67 613 1992 10.1136/adc.67.5.613 Cucchiara S.; Riezzo G.; Minella R.; Pezzolla F.; Giorgio I.; Auricchio S.; Electrogastrography in non-ulcer dyspepsia. Arch Dis Child 1992,67(5),613-617 Dig Dis Sci Riezzo G. 45 517 2000 10.1023/A:1005493123557 Riezzo G.; Chiloiro M.; Guerra V.; Borrelli O.; Salvia G.; Cucchiara S.; Comparison of gastric electrical activity and gastric emptying in healthy and dyspeptic children. Dig Dis Sci 2000,45(3),517-524 J Pediatr Gastroenterol Nutr Friesen C.A. 42 265 2006 10.1097/01.mpg.0000189367.99416.5e Friesen C.A.; Lin Z.; Hyman P.E.; Electrogastrography in pediatric functional dyspepsia: relationship to gastric emptying and symptom severity. J Pediatr Gastroenterol Nutr 2006,42(3),265-269 Digestion DuPont A.W. 89 119 2014 10.1159/000356314 DuPont A.W.; Jiang Z.D.; Harold S.A.; Motility abnormalities in irritable bowel syndrome. Digestion 2014,89(2),119-123 BMC Gastroenterol Devanarayana N.M. 16 26 2016 10.1186/s12876-016-0435-2 Devanarayana N.M.; Rajindrajith S.; Benninga M.A.; Abdominal migraine in children: Association between gastric motility parameters and clinical characteristics. BMC Gastroenterol 2016,16(1),26 J Gastroenterol Hepatol Devanarayana N.M. 28 1161 2013 10.1111/jgh.12205 Devanarayana N.M.; Rajindrajith S.; Perera M.S.; Nishanthanie S.W.; Benninga M.A.; Gastric emptying and antral motility parameters in children with functional dyspepsia: Association with symptom severity. J Gastroenterol Hepatol 2013,28(7),1161-1166 J Pediatr Gastroenterol Nutr Devanarayana N.M. 56 443 2013 10.1097/MPG.0b013e31827f7a3d Devanarayana N.M.; Rajindrajith S.; Bandara C.; Shashiprabha G.; Benninga M.A.; Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children. J Pediatr Gastroenterol Nutr 2013,56(4),443-448 Neurogastroenterol Motil Devanarayana NM 24 420-425, e207 2012 10.1111/j.1365-2982.2011.01871.x Devanarayana NM; Rajindrajith S; Rathnamalala N; Samaraweera S; Benninga MA; Delayed gastric emptying rates and impaired antral motility in children fulfilling Rome III criteria for functional abdominal pain. Neurogastroenterol Motil 2012,24(5),420-425, e207 Gastroenterology Stanghellini V. 110 1036 1996 10.1053/gast.1996.v110.pm8612991 Stanghellini V.; Tosetti C.; Paternicò A.; Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996,110(4),1036-1042 Dig Dis Sci Gilja O.H. 41 689 1996 10.1007/BF02213124 Gilja O.H.; Hausken T.; Wilhelmsen I.; Berstad A.; Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996,41(4),689-696 J Pediatr Gastroenterol Nutr Olafsdottir E. 30 157 2000 10.1097/00005176-200002000-00012 Olafsdottir E.; Gilja O.H.; Aslaksen A.; Berstad A.; Fluge G.; Impaired accommodation of the proximal stomach in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 2000,30(2),157-163 World J Gastroenterol Portincasa P. 9 2293 2003 10.3748/wjg.v9.i10.2293 Portincasa P.; Moschetta A.; Baldassarre G.; Altomare D.F.; Palasciano G.; Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003,9(10),2293-2299 Gut Serra J. 48 14 2001 10.1136/gut.48.1.14 Serra J.; Azpiroz F.; Malagelada J.R.; Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001,48(1),14-19 Clin Sci (Lond) Lu C-L. 95 165 1998 10.1042/CS19980040 Lu C-L.; Chen C-Y.; Chang F-Y.; Lee S-D.; Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study. Clin Sci (Lond) 1998,95(2),165-169 J Neurogastroenterol Motil Lee O.Y. 16 120 2010 10.5056/jnm.2010.16.2.120 Lee O.Y.; Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil 2010,16(2),120-130 Am J Physiol Gastrointest Liver Physiol Mayer E.A. 280 G519 2001 10.1152/ajpgi.2001.280.4.G519 Mayer E.A.; Naliboff B.D.; Chang L.; Coutinho S.V.V.; Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001,280(4),G519-G524 World J Gastroenterol Devanarayana N.M. 24 2211 2018 10.3748/wjg.v24.i21.2211 Devanarayana N.M.; Rajindrajith S.; Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol 2018,24(21),2211-2235 Nall R. Nall R.; Undigested Food in Stool: Should I Be Worried. Healthline 2020. Available from: Expert Rev Gastroenterol Hepatol Chiou E. 4 293 2010 10.1586/egh.10.28 Chiou E.; Nurko S.; Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol 2010,4(3),293-304 Cochrane Database Syst Rev Huertas-Ceballos A. CD003017 2008 Huertas-Ceballos A.; Logan S.; Bennett C.; Macarthur C.; Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev 2008(1),CD003017 J Pediatr Gastroenterol Nutr LeBel A.A. 47 703 2008 10.1097/01.mpg.0000338966.70550.d1 LeBel A.A.; Pharmacology. J Pediatr Gastroenterol Nutr 2008,47(5),703-705 BMJ Ford A.C. 337 a2313 2008 10.1136/bmj.a2313 Ford A.C.; Talley N.J.; Spiegel B.M.R.; Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008,337,a2313 Rev Gastroenterol Mex Martínez-Vázquez M.A. 77 82 2012 10.1016/j.rgmx.2012.04.002 Martínez-Vázquez M.A.; Vázquez-Elizondo G.; González-González J.A.; Gutiérrez-Udave R.; Maldonado-Garza H.J.; Bosques-Padilla F.J.; Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: Systematic review and meta-analysis. Rev Gastroenterol Mex 2012,77(2),82-90 Biomed Res Int Pourmoghaddas Z 2014 2014 Pourmoghaddas Z; Saneian H; Roohafza H; Gholamrezaei A; Mebeverine for pediatric functional abdominal pain: A randomized, placebo-controlled trial. Biomed Res Int 2014,2014 World J Gastroenterol Darvish-Damavandi M. 16 547 2010 10.3748/wjg.v16.i5.547 Darvish-Damavandi M.; Nikfar S.; Abdollahi M.; A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010,16(5),547-553 J Pediatr Bahar R.J. 152 685 2008 10.1016/j.jpeds.2007.10.012 Bahar R.J.; Collins B.S.; Steinmetz B.; Ament M.E.; Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr 2008,152(5),685-689 Gastroenterology Saps M. 137 1261 2009 10.1053/j.gastro.2009.06.060 Saps M.; Youssef N.; Miranda A.; Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology 2009,137(4),1261-1269 Circulation Gutgesell H. 99 979 1999 10.1161/01.CIR.99.7.979 Gutgesell H.; Atkins D.; Barst R.; Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1999,99(7),979-982 Dig Dis Sci See M.C. 46 985 2001 10.1023/A:1010793408132 See M.C.; Birnbaum A.H.; Schechter C.B.; Goldenberg M.M.; Benkov K.J.; Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: Global and quantitative assessment. Dig Dis Sci 2001,46(5),985-992 Paediatr Drugs Gibbons T.E. 5 25 2003 10.2165/00128072-200305010-00003 Gibbons T.E.; Gold B.D.; The use of proton pump inhibitors in children: A comprehensive review. Paediatr Drugs 2003,5(1),25-40 Curr Opin Pharmacol Tack J. 8 690 2008 10.1016/j.coph.2008.09.009 Tack J.; Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol 2008,8(6),690-696 Aliment Pharmacol Ther Drossman D.A. 29 329 2009 10.1111/j.1365-2036.2008.03881.x Drossman D.A.; Chey W.D.; Johanson J.F.; Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther 2009,29(3),329-341 Aliment Pharmacol Ther Thabane M. 26 535 2007 10.1111/j.1365-2036.2007.03399.x Thabane M.; Kottachchi D.T.; Marshall J.K.; Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007,26(4),535-544 BMJ Bardisa-Ezcurra L. 340 c2585 2010 10.1136/bmj.c2585 Bardisa-Ezcurra L.; Ullman R.; Gordon J.; Diagnosis and management of idiopathic childhood constipation: Summary of NICE guidance. BMJ 2010,340,c2585 Dig Dis Sci Cann P.A. 29 239 1984 10.1007/BF01296258 Cann P.A.; Read N.W.; Holdsworth C.D.; Barends D.; Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci 1984,29(3),239-247 Indian pediatri Paul SP 50 1137 2013 10.1007/s13312-013-0308-5 Paul SP; Barnard P; Bigwood C; Candy DC; Challenges in management of irritable bowel syndrome in children. Indian pediatri 2013,50(12),1137-43 J Pediatr Gastroenterol Nutr Guandalini S 51 24 2010 10.1097/MPG.0b013e3181ca4d95 Guandalini S; Magazzu G; Chiaro A; La Balestra V; Di Nardo G; Gopalan S; Sibal A; Romano C; Canani RB; Lionetti P; Setty M; VSL# 3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, doubleblind, crossover study. J Pediatr Gastroenterol Nutr 2010,51(1),24-30 Eur Rev Med Pharmacol Sci Scarpellini E 17 1314 Scarpellini E; Giorgio V; Gabrielli M; Filoni S; Vitale G; Tortora A; Ojetti V; Gigante G; Fundarò C; Gasbarrini A; Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome: a preliminary study. Eur Rev Med Pharmacol Sci ,17(10),1314-20